ATE479101T1 - Verfahren zur quantifizierung von denaturiertem lipoprotein - Google Patents
Verfahren zur quantifizierung von denaturiertem lipoproteinInfo
- Publication number
- ATE479101T1 ATE479101T1 AT02746016T AT02746016T ATE479101T1 AT E479101 T1 ATE479101 T1 AT E479101T1 AT 02746016 T AT02746016 T AT 02746016T AT 02746016 T AT02746016 T AT 02746016T AT E479101 T1 ATE479101 T1 AT E479101T1
- Authority
- AT
- Austria
- Prior art keywords
- lipoprotein
- antibody against
- denaturated
- quantifying
- determining
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/04—Phospholipids, i.e. phosphoglycerides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001212522 | 2001-07-12 | ||
PCT/JP2002/007116 WO2003006989A1 (fr) | 2001-07-12 | 2002-07-12 | Procede de quantification de lipoproteines denaturees, reactifs pour la quantification de lipoproteines denaturees, procede de detection de maladies du systeme circulatoire et reactifs pour la detection de maladies du systeme circulatoire |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE479101T1 true ATE479101T1 (de) | 2010-09-15 |
Family
ID=19047672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02746016T ATE479101T1 (de) | 2001-07-12 | 2002-07-12 | Verfahren zur quantifizierung von denaturiertem lipoprotein |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040241744A1 (de) |
EP (1) | EP1418429B1 (de) |
JP (2) | JP4179988B2 (de) |
KR (1) | KR20040025931A (de) |
CN (1) | CN100516878C (de) |
AT (1) | ATE479101T1 (de) |
CA (1) | CA2453538A1 (de) |
DE (1) | DE60237455D1 (de) |
WO (1) | WO2003006989A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE546734T1 (de) * | 2003-12-05 | 2012-03-15 | Cleveland Clinic Foundation | Risikomarker für eine herzkreislaufkrankheit |
US7807378B2 (en) * | 2005-12-29 | 2010-10-05 | Industrial Technology Research Institute (Itri) | Method of diagnosing myasthenia gravis and kits therefor |
FI20075245A0 (fi) * | 2007-04-11 | 2007-04-11 | Markku Ahotupa | Menetelmä oksidatiivisen metabolian arvioimiseksi |
CN104198690B (zh) * | 2007-06-08 | 2016-09-07 | 奎斯特诊断投资公司 | 通过差分带电荷微粒迁移率进行脂蛋白分析 |
US20110104823A1 (en) * | 2008-07-11 | 2011-05-05 | Owen Whyte G | Measuring lipoprotein containing particles |
WO2010025434A1 (en) * | 2008-08-29 | 2010-03-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
JP2012506537A (ja) | 2008-10-21 | 2012-03-15 | アスチュート メディカル,インコーポレイテッド | 腎損傷および腎不全の診断および予後のための方法および組成物 |
EP2405275B1 (de) * | 2009-03-05 | 2018-10-10 | BML, Inc. | Messmethode für glykosyliertes Albumin in Serum oder Plasma unter Verwendung von Mannitol als Stabilisator für das Kontrollserum oder -plasma. |
CN102472752B (zh) * | 2009-08-28 | 2015-08-19 | B.R.A.H.M.S有限公司 | 用于不良事件的预后的降钙素原 |
CN102576012B (zh) * | 2009-09-18 | 2015-07-15 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后方法和组合物 |
EP3339860A1 (de) | 2010-06-23 | 2018-06-27 | Astute Medical, Inc. | Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz |
JP6231307B2 (ja) * | 2013-06-27 | 2017-11-15 | 中野 恵正 | 機能不全hdlの測定方法、機能不全hdl測定用キット、並びに、生活習慣病マーカーの測定方法 |
KR20160091276A (ko) * | 2015-01-23 | 2016-08-02 | 바디텍메드(주) | Cdc 단백질 및 콜레스테롤 항체를 이용한 콜레스테롤 측정 방법 |
CN110431422A (zh) | 2017-02-06 | 2019-11-08 | 机敏医药股份有限公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
JP6859215B2 (ja) * | 2017-04-17 | 2021-04-14 | 日本光電工業株式会社 | 脂質二重膜粒子またはその断片の検出方法 |
CN107271674B (zh) * | 2017-06-13 | 2019-05-07 | 首都医科大学附属北京地坛医院 | 一种用于脂肪性肝炎检测的靶标志物gp73及检测应用方法 |
CN107807245A (zh) * | 2017-10-25 | 2018-03-16 | 阮雄中 | 一种细胞内胆固醇敏感度和定位的测量方法及其诊断试剂 |
CN115698713A (zh) * | 2020-03-30 | 2023-02-03 | 国立大学法人信州大学 | 改性hdl的定量方法以及用于该定量方法的分析用试剂 |
WO2023129186A1 (en) * | 2022-01-03 | 2023-07-06 | Kerth Corp. | Biological kit for separating electronegative low density lipoprotein from specimen, reagent solution and method for separating electronegative low density lipoprotein from specimen |
WO2023167232A1 (ja) * | 2022-03-01 | 2023-09-07 | 旭化成ファーマ株式会社 | オートタキシン測定試薬のキャリブレーター、オートタキシン測定試薬のキャリブレーション方法、オートタキシン測定キット、オートタキシンの測定方法、診断補助キット、及び診断補助方法 |
CN117192134A (zh) * | 2023-09-14 | 2023-12-08 | 宁波美康盛德生物科技有限公司 | 一种氧化型低密度脂蛋白的检测试剂盒、检测方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
DE3751182T2 (de) * | 1986-08-06 | 1995-10-26 | Scripps Clinic Res | Monoklonale Antikörper, B-spezifisch für Apolipoprotein, die von zwei Hybridomen erzeugt werden. |
US4828986A (en) * | 1986-09-29 | 1989-05-09 | Scripps Clinic And Research Foundation | Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample |
CA1335077C (en) * | 1988-02-08 | 1995-04-04 | Henri Isliker | Process for the manufacture of apolipoproteins from human blood plasma or serum |
JPH07104351B2 (ja) * | 1988-09-29 | 1995-11-13 | 株式会社日本抗体研究所 | 脂質代謝異常検出用キット |
JP3356556B2 (ja) * | 1993-10-22 | 2002-12-16 | 第一化学薬品株式会社 | 変性リポプロテイン類の測定法 |
JPH08228774A (ja) * | 1995-02-27 | 1996-09-10 | Toagosei Co Ltd | ペルオキシダーゼまたはペルオキシダーゼ標識抗体の安定化方法 |
US5689961A (en) * | 1996-01-30 | 1997-11-25 | Organogenesis Inc. | Ice seeding apparatus for cryopreservation systems |
JP3872880B2 (ja) * | 1997-10-21 | 2007-01-24 | アルフレッサファーマ株式会社 | 感作金属コロイド含有安定化凍結乾燥物及びその製造方法 |
ES2205853T3 (es) * | 1998-07-03 | 2004-05-01 | Athera Biotechnologies Ab | Metodo para diagnosticar la enfermedad cardiovascular y la aterosclerosis precoz. |
ATE358683T1 (de) * | 1999-06-02 | 2007-04-15 | Kyowa Medex Co Ltd | Stabilisiertes denaturiertes lipoprotein und verfahren zu dessen herstellung |
JP3491743B2 (ja) * | 1999-08-31 | 2004-01-26 | 株式会社いかがく | 血液中の変性リポ蛋白の検出方法 |
-
2002
- 2002-07-12 DE DE60237455T patent/DE60237455D1/de not_active Expired - Lifetime
- 2002-07-12 JP JP2003512706A patent/JP4179988B2/ja not_active Expired - Fee Related
- 2002-07-12 AT AT02746016T patent/ATE479101T1/de not_active IP Right Cessation
- 2002-07-12 CA CA002453538A patent/CA2453538A1/en not_active Abandoned
- 2002-07-12 CN CNB028175778A patent/CN100516878C/zh not_active Expired - Fee Related
- 2002-07-12 KR KR10-2004-7000399A patent/KR20040025931A/ko active IP Right Grant
- 2002-07-12 EP EP02746016A patent/EP1418429B1/de not_active Expired - Lifetime
- 2002-07-12 WO PCT/JP2002/007116 patent/WO2003006989A1/ja active Application Filing
- 2002-07-12 US US10/483,146 patent/US20040241744A1/en not_active Abandoned
-
2008
- 2008-04-08 JP JP2008100657A patent/JP4904308B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1418429B1 (de) | 2010-08-25 |
WO2003006989A1 (fr) | 2003-01-23 |
EP1418429A1 (de) | 2004-05-12 |
KR20040025931A (ko) | 2004-03-26 |
JP4904308B2 (ja) | 2012-03-28 |
JPWO2003006989A1 (ja) | 2004-11-04 |
CN1554024A (zh) | 2004-12-08 |
US20040241744A1 (en) | 2004-12-02 |
CN100516878C (zh) | 2009-07-22 |
EP1418429A4 (de) | 2008-04-02 |
JP4179988B2 (ja) | 2008-11-12 |
JP2008203269A (ja) | 2008-09-04 |
DE60237455D1 (de) | 2010-10-07 |
CA2453538A1 (en) | 2003-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE479101T1 (de) | Verfahren zur quantifizierung von denaturiertem lipoprotein | |
ATE405832T1 (de) | Verfahren zur erhöhung des dynamischen messbereichs von auf spezifischen bindereaktionen basierenden, insbesondere immunologischen testelementen | |
ATE516492T1 (de) | Vorrichtung und verfahren zur multianalytbestimmung | |
MX2007014815A (es) | Metodos de inmunoanalisis mejorados. | |
DE69839149D1 (de) | Methode und vorrichtung zum nachweis oder zur quantifizierung von kohlenhydrate enthaltenden verbindungen | |
WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
DE602005013225D1 (de) | Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten | |
DE69920937D1 (de) | Verfahren zur quantifizierung von cholesterol in lipoproteinen und quantifizierungsreagenzien | |
WO2006047591A3 (en) | Rapid microfluidic assay for analyte interactions | |
ATE508365T1 (de) | Immunologisch-analytisches verfahren zur bestimmung von glykosylierten proteinen (ages) | |
WO2008118558A3 (en) | Improved antibody profiling sensitivity through increased reporter antibody layering | |
ATE545460T1 (de) | Proteomanalyseverfahren für phosphoryliertes protein | |
DE60021369D1 (de) | Verfahren zur abschätzung eines magengeschwür-risikos | |
GB2437545B (en) | Dextrin-containing reagents for detecting and quantifying proteins | |
ATE333091T1 (de) | Verfahren zur messung von blutersatzstoffen | |
ATE524737T1 (de) | Verfahren und vorrichtung zur bestimmung mehrerer analyten mit simultaner internen kontrolle in einer grafischen kombination | |
DE69942215D1 (de) | Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers | |
ATE368855T1 (de) | Immunnephelometrie von lipoprotein (a) und reagens dafür | |
WO2003029813A3 (de) | Teststreifen für den nachweis von prionproteinen | |
ATE421093T1 (de) | Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten | |
DE60121547D1 (de) | Electrochemisches verfahren zum nachweis von nukleinsäuren | |
ATE278965T1 (de) | Knorpelresorptionsassays | |
ATE520985T1 (de) | Verfahren zur bestimmung von antigen und antikörper gegen das antigen | |
ATE347108T1 (de) | Zusammensetzungen und verfahren zum bestimmen von aa4rp | |
RU2001132334A (ru) | Способ идентификации индивидуума, у которого существует риск необратимых неврологических повреждений, включающий в себя этапы количественного определения концентрации пепсиногена i (pgi) и витамина в12 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |